This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Aug 12;116(6):860-1.

doi: 10.1182/blood-2010-05-285163.

The substrate is down: is the IV out?

Jeff Szer¹

Affiliations

PMID: 20705763
DOI: 10.1182/blood-2010-05-285163

Free article

Comment

The substrate is down: is the IV out?

Jeff Szer. Blood. 2010.

Free article

. 2010 Aug 12;116(6):860-1.

doi: 10.1182/blood-2010-05-285163.

Author

Jeff Szer¹

Affiliation

¹ Royal Melbourne Hospital.

PMID: 20705763
DOI: 10.1182/blood-2010-05-285163

No abstract available

PubMed Disclaimer

Comment on

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.
Lukina E, Watman N, Arreguin EA, Banikazemi M, Dragosky M, Iastrebner M, Rosenbaum H, Phillips M, Pastores GM, Rosenthal DI, Kaper M, Singh T, Puga AC, Bonate PL, Peterschmitt MJ. Lukina E, et al. Blood. 2010 Aug 12;116(6):893-9. doi: 10.1182/blood-2010-03-273151. Epub 2010 May 3. Blood. 2010. PMID: 20439622 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems